Zylox-Tonbridge Medical Technology Co., Ltd. (2190.HK)
HKD 11.12
(0.18%)
HKD 11.12
(0.18%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 527.75 Million CNY | 57.97% |
| 2022 | 334.09 Million CNY | 87.78% |
| 2021 | 177.91 Million CNY | 543.89% |
| 2020 | 27.63 Million CNY | 461.95% |
| 2019 | 4.91 Million CNY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 182.99 Million CNY | 0.0% |
| 2024 Q1 | 182.99 Million CNY | 22.97% |
| 2023 FY | 527.75 Million CNY | 57.97% |
| 2023 Q2 | 115.06 Million CNY | 0.0% |
| 2023 Q4 | 148.81 Million CNY | 0.0% |
| 2023 Q1 | 115.06 Million CNY | 26.9% |
| 2023 Q3 | 148.81 Million CNY | 29.33% |
| 2022 Q2 | 76.37 Million CNY | 0.0% |
| 2022 FY | 334.09 Million CNY | 87.78% |
| 2022 Q3 | 90.67 Million CNY | 18.73% |
| 2022 Q1 | 76.37 Million CNY | 43.52% |
| 2022 Q4 | 90.67 Million CNY | 0.0% |
| 2021 Q3 | 53.21 Million CNY | 48.88% |
| 2021 Q2 | 35.74 Million CNY | 0.0% |
| 2021 FY | 177.91 Million CNY | 543.89% |
| 2021 Q4 | 53.21 Million CNY | 0.0% |
| 2021 Q1 | 35.74 Million CNY | 180.08% |
| 2020 FY | 27.63 Million CNY | 461.95% |
| 2020 Q3 | 12.76 Million CNY | 1110.77% |
| 2020 Q1 | 1.05 Million CNY | 0.0% |
| 2020 Q2 | 1.05 Million CNY | 0.0% |
| 2020 Q4 | 12.76 Million CNY | 0.0% |
| 2019 FY | 4.91 Million CNY | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Vincent Medical Holdings Limited | 717.97 Million HKD | 26.494% |